Wound Treatments in Saudi Arabia
Euromonitor International's Wound Treatments in Saudi Arabia market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 34 | Publication date: Jun 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Other wound treatments; Sticking plasters
Table of contents
WOUND TREATMENTS IN SAUDI ARABIA : MARKET INSIGHT
SECTOR DATA
Table 1 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 2 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 3 Wound Treatments Company Shares by Value 2004-2008
Table 4 Wound Treatments Brand Shares by Value 2005-2008
Table 5 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 6 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - SAUDI ARABIA
JAMJOOM PHARMA - OTC HEALTHCARE - SAUDI ARABIA
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Jamjoom Pharma: Key Facts
Summary 2 Jamjoom Pharma: Operational Indicators 2006-2008
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 3 Jamjoom Pharma: Competitive Position 2008
JULPHAR GULF PHARMACEUTICALS - OTC HEALTHCARE - SAUDI ARABIA
STRATEGIC DIRECTION
KEY FACTS
Summary 4 Julphar Gulf Pharmaceuticals: Key Facts
Summary 5 Julphar Gulf Pharmaceuticals: Operational Indicators 2006-2008
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 6 Julphar Gulf Pharmaceuticals: Competitive Position 2008
RIYADH PHARMA - OTC HEALTHCARE - SAUDI ARABIA
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Riyadh Pharma: Key Facts
Summary 8 Riyadh Pharma: Operational Indicators 2006-2008
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 9 Riyadh Pharma: Competitive Position 2008
SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CO (SPIMACO) - OTC HEALTHCARE - SAUDI ARABIA
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO): Key Facts
Summary 11 Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO): Operational Indicators 2006-2008
COMPANY BACKGROUND
PRODUCTION
Summary 12 Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO): Production Statistics 2007
COMPETITIVE POSITIONING
Summary 13 Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO): Competitive Position 2008
TABUK PHARMACEUTICAL MANUFACTURING CO - OTC HEALTHCARE - SAUDI ARABIA
STRATEGIC DIRECTION
KEY FACTS
Summary 14 Tabuk Pharmaceutical Manufacturing Co: Key Facts
Summary 15 Tabuk Pharmaceutical Manufacturing Co: Operational Indicators 2006-2008
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 16 Tabuk Pharmaceutical Manufacturing Co: Competitive Position 2008
OTC HEALTHCARE IN SAUDI ARABIA
EXECUTIVE SUMMARY
Sales advance at a rate on par with growth registered over the review period
Global economic downturn had no impact on Saudi OTC healthcare in 2008
SPIMACO maintains leadership but other local manufacturers gain in importance
Gradual shift towards a new OTC retailing system continued in 2008
Saudi OTC healthcare to see a lower CAGR over the forecast period
KEY TRENDS AND DEVELOPMENTS
Saudi economy continues to perform in 2008 despite the global financial crisis
Increasing penetration of OTC products due to lower unit prices
Health risks, the climate and demographic factors drive strong demand
New product development fuelled rapid growth of many sectors
Increasing level of competition favours overall OTC healthcare
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 8 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 9 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 10 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 11 OTC Healthcare Company Shares by Value 2004-2008
Table 12 OTC Healthcare Brand Shares by Value 2005-2008
Table 13 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 14 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 15 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 16 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 17 OTC Healthcare Switches
DEFINITIONS
Summary 18 Research Sources